Journal metric profile

ADVANCES IN CHRONIC KIDNEY DISEASE

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 2.300 2025 metric year
5-Year Impact Factor 3.800 Longer citation window
JCR Quartile Q2 Subject-category quartile
JCR Category Rank 54/133 Recorded category rank

ADVANCES IN CHRONIC KIDNEY DISEASE JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

ADVANCES IN CHRONIC KIDNEY DISEASE metric snapshot

ADVANCES IN CHRONIC KIDNEY DISEASE has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is W B SAUNDERS CO-ELSEVIER INC. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 2.300. The five-year Journal Impact Factor is 3.800, giving a second citation window for comparison. The journal is recorded in quartile Q2 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 54 out of 133 journals. Based on that rank position, the journal sits within approximately the top 41% of the listed category. Its listed quartile is Q2. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (3.800) is 1.500 points higher than the standard Journal Impact Factor (2.300). The Impact Factor without journal self-citations is the same as the listed standard value at the displayed precision. The Journal Citation Indicator (JCI) is recorded as 0.800. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for ADVANCES IN CHRONIC KIDNEY DISEASE lists total cites: 2,991; total articles: 0; citable items: 0. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 7.8 years, indicating the median age of items that contributed citations to the journal in the reporting framework.

Identifiers and verification

ADVANCES IN CHRONIC KIDNEY DISEASE is identified in this directory by print ISSN 1548-5595 and electronic ISSN 1548-5609. The publisher is recorded as W B SAUNDERS CO-ELSEVIER INC. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameADVANCES IN CHRONIC KIDNEY DISEASE
Abbreviated journalADV CHRONIC KIDNEY D
PublisherW B SAUNDERS CO-ELSEVIER INC
Metric year2025
Overall rank7,030
ISSN1548-5595
eISSN1548-5609
Total cites2,991
Total articles0
Citable items0
Cited half-life7.8 years
Citing half-lifeNot available
JCR-based Journal Impact Factor2.300
5-Year Impact Factor3.800
Impact Factor without journal self-cites2.300
Journal Citation Indicator0.800
JCR Impact Factor quartileQ2
JCR category rank54/133
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of ADVANCES IN CHRONIC KIDNEY DISEASE?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for ADVANCES IN CHRONIC KIDNEY DISEASE is 2.300 for the 2025 metric year.

What are the JCR quartile and category rank of ADVANCES IN CHRONIC KIDNEY DISEASE?

ADVANCES IN CHRONIC KIDNEY DISEASE is listed with quartile Q2 and category rank 54/133. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of ADVANCES IN CHRONIC KIDNEY DISEASE?

The five-year Journal Impact Factor recorded for ADVANCES IN CHRONIC KIDNEY DISEASE is 3.800. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes ADVANCES IN CHRONIC KIDNEY DISEASE?

ADVANCES IN CHRONIC KIDNEY DISEASE is listed in this directory as being published by W B SAUNDERS CO-ELSEVIER INC.

Additional records from the same publisher or with a similar listed JCR Impact Factor.